Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01720472 · ClinicalTrials.gov registry record
Implementing a Physical and Cognitive Performance Assessment Cohort in the MURDOCK Study Community Registry and Biorepository
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT01720472 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 1,000 participants.
The verdict
NCT01720472 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The purpose of this study is to use the MURDOCK Horizon 1.5 infrastructure (Duke Instutional Review Board Pro00011196) to specifically target and enroll 1,000 participants across age groups and other demographic categories in order to develop a diverse cohort with specific physical and cognitive performance data paired with biological samples.
Interventions
- GENETIC Biomarker studies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2012-05 |
| Est. Completion | 2018-08-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01720472
The ClinicalTrials.gov registry entry for NCT01720472 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biomarker studies is the first listed.
NCT01720472 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01720472 about?
NCT01720472 is a clinical study titled "Implementing a Physical and Cognitive Performance Assessment Cohort in the MURDOCK Study Community Registry and Biorepository". The purpose of this study is to use the MURDOCK Horizon 1.5 infrastructure (Duke Instutional Review Board Pro00011196) to specifically target and enroll 1,000 participants across age groups and other demographic categories in order to develop a diverse cohort with specific physical and cognitive per...
What is the current status of trial NCT01720472?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2012-05. Estimated completion is 2018-08-28.
What interventions are being tested in trial NCT01720472?
The interventions under investigation include: Biomarker studies (GENETIC).
Who is sponsoring clinical trial NCT01720472?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.